• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Demographic Analysis of Mortality Changes Associated With the COVID-19 Pandemic in Japan, 2020-2022

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2025 Dec;19(12):e70196.
doi: 10.1111/irv.70196. Demographic Analysis of Mortality Changes Associated With the COVID-19 Pandemic in Japan, 2020-2022

Yuta Okada[SUP] 1 [/SUP], Hiroshi Nishiura[SUP] 1 [/SUP]



Affiliations
Abstract

Backgrounds: Demographic analysis is required to thoroughly evaluate the mortality impact of COVID-19 in Japan that cannot be captured by epidemiological surveillance.
Methods: A hierarchical time-varying regression model was applied to prefectural life table data in Japan during 2000-2019. Pre-pandemic baseline mortality rates and death counts during 2020-2022 were projected by this model to evaluate the mortality impact of the COVID-19 pandemic on mortality during 2020-2022.
Results: Nationally, the observed mortality rates were higher than projected rates among those aged 10-29 years and lower for ages 1-9 and > 80 years in 2020. During 2021 and 2022, mortality rates consistently increased for most age groups, with substantial regional heterogeneity in those aged < 14 years. Consistently, the neutral gaps between the observed and projected life expectancy across prefectures in 2020 turned negative in most prefectures during 2022. In 2022, the negative gap in life expectancy ranged from a substantial shortening of -1.50 years (95% prediction interval [PI]: -1.82, -1.16) in Okinawa to a slight shortening of -0.21 years (95% PI: -0.65, 0.22) in Tottori. Excess deaths per population also grew consistently in all prefectures during 2020-2022; Miyazaki yielded the largest estimate at 177.4 (95% PI: 144.9, 210.2) per 100,000 population.
Conclusions: Our framework highlights the usefulness of life table data for evaluating the mortality impact caused by an event such as the pandemic. Our estimates, adjusted by pre-pandemic demographic trends, revealed the massive mortality impact of the COVID-19 pandemic across a wide age range.

Keywords: Bayesian hierarchical model; COVID‐19; Japan; excess death; life table.

 
Back
Top Bottom